Literature DB >> 17338907

Is minimally invasive surgery less invasive in total hip replacement? A pilot study.

P Pilot1, B Kerens, W F Draijer, N P Kort, J ten Kate, W A Buurman, H Kuipers.   

Abstract

It has been suggested that minimally invasive surgery (MIS) in total hip replacement (THR) is less traumatic than standard techniques. This study was designed to address the question of whether an anterior MIS approach generates less inflammation and muscle damage than the standard posterolateral (PL) approach. Inflammation parameters such as interleukin-6 (IL-6), muscle damage parameters like heart type fatty acid binding protein (H-FABP), and haemoglobin (Hb) levels were determined pre-operatively and at five consecutive points post-operatively in 10 patients operated through a MIS anterior approach and in 10 patients operated through a PL approach. The mean IL-6 concentration increased from 3 pg/ml in both groups pre-operatively to 78.5 pg/ml (PL group) vs 74.8 pg/ml (MIS group) at 6 hours post-operatively and reached a maximum of 100 pg/ml (PL group) vs 90.5 pg/ml pg/ml (MIS group) after 24 hours. Up to this time point, there was a decrease in both groups. The post-operative mean H-FABP concentration increased to 10.7 microg/l in the PL group vs 15.8 microg/l in the MIS group. It formed a plateau and decreased after 24 hours post-operatively. The Hb levels were 14.5 g/dl before surgery and decreased to 10.7 g/dl (PL group) and 10.0 g/dl (MIS group) at 72 hours post-operatively. No significant differences were found between the two approaches either in inflammation and muscle damage or blood loss. Although the absence of a learning curve may explain the lack of a difference between both techniques, we speculate that the term MIS is at least doubtful in terms of being less traumatic.

Entities:  

Mesh:

Year:  2006        PMID: 17338907     DOI: 10.1016/S0020-1383(07)70007-4

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  7 in total

1.  [Minimally invasive total hip arthroplasty - trend or state of the art?: A meta-analysis].

Authors:  T Kappe; R Bieger; D Wernerus; H Reichel
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

2.  Anterior muscle sparing approach for total hip arthroplasty.

Authors:  Joseph T Moskal; Susan G Capps; John A Scanelli
Journal:  World J Orthop       Date:  2013-01-18

3.  Orthopaedic trauma surgeons and direct anterior total hip arthroplasty: evaluation of learning curve at a level I academic institution.

Authors:  Philip J York; Stephanie L Logterman; David J Hak; Andreas Mavrogenis; Cyril Mauffrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-03

Review 4.  Serum biomarkers for the assessment of muscle damage in various surgical approaches in primary total hip arthroplasty: a systematic review of comparative studies.

Authors:  Michael G Sarantis; Panagiotis I Mandrekas; Sophia Stasi; Konstantinos Makris; George A Macheras; Andreas F Mavrogenis; George C Babis; Vasilios S Nikolaou
Journal:  Int Orthop       Date:  2022-06-01       Impact factor: 3.479

5.  Supercapsular Percutaneously Assisted total hip arthroplasty versus lateral approach in Total Hip Replacement. A prospective comparative study.

Authors:  Stylianos Tottas; Christina Tsigalou; Athanasios Ververidis; Ioannis E Kougioumtzis; Makrina Karaglani; Konstantinos Tilkeridis; Christos Chatzipapas; Georgios I Drosos
Journal:  J Orthop       Date:  2020-08-16

6.  Does a minimal invasive approach reduce anterior chest wall numbness and postoperative pain in plate fixation of clavicle fractures?

Authors:  Marc Beirer; Lukas Postl; Moritz Crönlein; Sebastian Siebenlist; Stefan Huber-Wagner; Karl F Braun; Peter Biberthaler; Chlodwig Kirchhoff
Journal:  BMC Musculoskelet Disord       Date:  2015-05-28       Impact factor: 2.362

7.  Total hip arthroplasty through an anterior approach: The pros and cons.

Authors:  Georgios Kyriakopoulos; Lazaros Poultsides; Panayiotis Christofilopoulos
Journal:  EFORT Open Rev       Date:  2018-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.